SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-253755
Filing Date
2011-09-22
Accepted
2011-09-22 08:30:58
Documents
3
Period of Report
2011-10-27
Effectiveness Date
2011-09-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d229775ddef14a.htm DEF 14A 262059
2 GRAPHIC g229775g02u98.jpg GRAPHIC 10005
3 GRAPHIC g229775g70l52.jpg GRAPHIC 6593
  Complete submission text file 0001193125-11-253755.txt   286566
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 111102283
SIC: 2834 Pharmaceutical Preparations